Effects of Caffeine on Plasma Renin Activity, Catecholamines and Blood Pressure

10.1111/j.0954-6820.1967.tb07260.x

Eichler O: Kaffee und Coffein. Second edition. Berlin, Springer, 1975, pp 65–320

Beavo, 1970, Mol Pharmacol, 6, 597

10.1056/NEJM197307122890203

Boston Collaborative Drug Surveillance Program, 1972, Lancet, 2, 1278

10.1159/000165261

Scott, 1944, J Pharmacol Exp Ther, 82, 89

Dalla Torre, 1952, Minerva Med, 43, 853

Colton, 1968, Clin Pharmacol Ther, 9, 31, 10.1002/cpt19689131

Grollman, 1930, J Pharmacol Exp Ther, 39, 313

10.1172/JCI100906

Stepp, 1938, Arch Exp Pathol Pharmakol, 190, 156

Haldi, 1944, J Nutr, 27, 287, 10.1093/jn/27.4.287

10.1001/archinte.130.6.849

10.1016/0003-2697(73)90517-4

Axelrod, 1958, J Biol Chem, 233, 702, 10.1016/S0021-9258(18)64731-3

Eddy, 1928, J Pharmacol Exp Ther, 33, 167

10.1037/h0071270

Robertson, 1977, Fed Proc, 36, 956

Horning, 1977, Clin Chem, 23, 157, 10.1093/clinchem/23.2.157

10.1161/01.CIR.35.4.745

10.1016/0026-0495(69)90049-3

Zicha, 1969, Med Welt, 30, 1674

Laragh JH, Baer L, Brunner HR, et al: The renin–angiotensin–aldosterone system in pathogenesis and management of hypertensive vascular disease, Hypertension Manual. Edited by JH Laragh. New York, Dun-Donnelley, 1974, p 320

10.1056/NEJM197702242960801

Kuchel O: Autonomic nervous system in hypertension: clinical aspects, Hypertension Pathophysiology and Treatment. Edited by J Genest. New York, McGraw-Hill, 1977, pp 93–114

Fleisch, 1954, Schweiz Med Wochenschr, 84, 223

10.1007/BF02630203

Sollmann, 1911, J Pharmacol Exp Ther, 3, 19

10.1080/00221309.1939.10544302

Marbach, 1962, C R Soc Biol (Paris), 156, 1522

10.1056/NEJM197410242911703

10.1001/jama.226.5.540

10.1056/NEJM197603182941203

Rotenberg, 1976, Fed Proc, 35, 384